{"id":"W4405828684","doi":"10.1177/1877718x241300295","title":"Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies","year":2024,"lang":"en","type":"article","venue":"Journal of Parkinson s Disease","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Alberta","funders":"Sanofi Genzyme; Horizon 2020 Framework Programme; Sun Pharma; Sunovion; H. Lundbeck A/S; Boston Scientific Corporation; EVER Neuro Pharma; Ipsen; Centre Hospitalier Universitaire de Toulouse; Servier; Acorda Therapeutics; Institut National de la Santé et de la Recherche Médicale; European Commission; Association France Parkinson; Agence Nationale de la Recherche; Parkinson's UK; Chiesi USA; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Pfizer; Biogen; Medtronic; Sanofi; Allergan; AstraZeneca; Direction de l’hospitalisation et de l’offre de Soins; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Deferiprone; Parkinson's disease; Medicine; Disease; Internal medicine; Deferoxamine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003520266,0.0008095781,0.00174565,0.0004818752,0.0003101717,0.0006970626,0.0007237314,0.0008284852,0.003997515],"category_scores_gemma":[0.001527706,0.0002464442,0.001383843,0.0005009403,0.0006778415,0.000900372,0.0005440885,0.001223628,0.0004631441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005409791,"about_ca_system_score_gemma":0.0007551861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006382241,"about_ca_topic_score_gemma":0.00325151,"domain_scores_codex":[0.9990607,0.0005487894,0.0000970038,0.00007852897,0.0001353949,0.00007962713],"domain_scores_gemma":[0.9987143,0.0004460135,0.0003513031,0.0001086968,0.0001736559,0.0002059736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5532588,0.02130025,0.01493765,0.01137728,0.008641012,0.0003700083,0.0005677576,0.001161162,0.01964281,0.001598302,0.005041652,0.3621033],"study_design_scores_gemma":[0.3202408,0.5289288,0.08374139,0.002899575,0.01184057,0.0007604333,0.0006078421,0.0008484246,0.005368444,0.0009992186,0.04363273,0.0001317863],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8536922,0.1319555,0.0005289688,0.001654079,0.00022006,0.0008821934,0.001243492,0.00003985499,0.009783601],"genre_scores_gemma":[0.9215497,0.06709424,0.001730995,0.00258221,0.0006745252,0.001101728,0.00196186,0.00002082959,0.003283933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003997515,"threshold_uncertainty_score":0.01861715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03812069985095699,"score_gpt":0.3238525694828199,"score_spread":0.2857318696318629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}